Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 17)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
23-Nov-09Reuters Investment ProfileN/AAdeona Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
23-Nov-09Reuters Investment ProfileN/AAndes Energia Plc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
21-Nov-09Reuters Investment ProfileN/AAntrim Energy Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
16-Nov-09CIBC World MarketsRobert Pare CFA, John Prins CAAEN: Q3/09 Results Above Expectations; North Sea JV Agreement Could Be A Catalyst10$25  View Abstract
13-Nov-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
9-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Antrim Energy Inc.42$65  View Abstract
6-Nov-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
30-Oct-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
29-Oct-09Global Markets DirectGlobal Markets DirectAdeona Pharmaceuticals, Inc. Financial Analysis Review10$300  View Abstract
23-Oct-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
Next 7

Brokerage Reports (Showing 1 to 9 of 9)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
16-Nov-09CIBC World MarketsRobert Pare CFA, John Prins CAAEN: Q3/09 Results Above Expectations; North Sea JV Agreement Could Be A Catalyst10$25  View Abstract
13-Nov-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
6-Nov-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
30-Oct-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
23-Oct-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
21-Oct-09CIBC World MarketsRobert Pare CFA, John Prins CACommodity Deck Change8$25  View Abstract
16-Oct-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
9-Oct-09CIBC World MarketsRobert Pare CFA, Brad Borggard CFA, Christine Ezinga, Adam Gill, John Prins CA, Diana ChawThe Oil & Gas Trust/Junior Weekly21$75  View Abstract
20-Mar-09CIBC World MarketsMark Bridges CFA, Robert Pare CFA, Brad Borggard CFA, William S. Lee P. Eng, Christine Ezinga, Adam Gill, Vladislav Vlad, John Prins CAThe Oil & Gas Trust/Junior Weekly21$90  View Abstract

Independent Reports (Showing 1 to 8 of 8)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
23-Nov-09Reuters Investment ProfileN/AAdeona Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
23-Nov-09Reuters Investment ProfileN/AAndes Energia Plc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
21-Nov-09Reuters Investment ProfileN/AAntrim Energy Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
9-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Antrim Energy Inc.42$65View Abstract
29-Oct-09Global Markets DirectGlobal Markets DirectAdeona Pharmaceuticals, Inc. Financial Analysis Review10$300View Abstract
15-Oct-09Global Markets DirectGlobal Markets DirectAndes Energia PLC Financial Analysis Review12$300View Abstract
30-Mar-09ValuEngine, Inc.N/AValuEngine Industry Report for BIOTECHNOLOGY18$49View Abstract
28-Mar-09ValuEngine, Inc.N/AValuEngine Detailed Valuation Report for AEN13$25View Abstract

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.